The Brazil Pharmaceutical Manufacturing Equipment Market was valued at $374.8 Million in 2026 and projected to reach to $516.2 Million by 2031, representing a compound annual growth rate of 5.5%. Brazil's pharmaceutical manufacturing equipment market is positioned for sustained growth through 2031, driven by government initiatives to strengthen domestic production capacity and regulatory compliance requirements.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Brazil's pharmaceutical manufacturing equipment market is valued at USD 374.8 million in 2026 and is projected to reach USD 516.2 million by 2031, demonstrating robust expansion in South America's life sciences sector.
Brazil's evolving regulatory environment is creating favorable conditions for pharmaceutical equipment manufacturers, with ANVISA (National Health Surveillance Agency) implementing stricter quality standards that drive demand for advanced manufacturing solutions.
Increased investment in local pharmaceutical manufacturing capabilities is reducing Brazil's dependency on imports, spurring demand for state-of-the-art equipment and automation technologies across production facilities.
As South America's largest pharmaceutical market, Brazil serves as a gateway for equipment suppliers targeting the broader Latin American region, with established distribution networks and manufacturing hubs.
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | PACKAGING MACHINES (Equipment Type) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 6.2% from 2026 to 2031 |
| Largest Segment | AUTOMATIC (Technology) |
| Market Size Base Year (Billions) | ~USD 21.18 (2026) |
| Revenue Forecast (Billions) | ~USD 28.62 (2031) |
| Segments Covered | Equipment Type, End-Product Type, Technology |
3 segment dimensions are covered across the global market.
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| GEA GROUP AKTIENGESELLSCHAFT | United States | Public Company | Separation & Flow Technologies,Liquid & Power Technologies,Food & Health Technologies, |
| KöRBER AG | Germany | Private Company | Supply chain software, automation, voice, robotics, and material handling,Pharma machinery, equipment, and related software,Technologies: measuring instruments, flavors, food and beverage, and e-mobility equipment, |
| IMA INDUSTRIA MACCHINE AUTOMATICHE SPA | Italy | Private Company | Pharmaceutical processing and packaging systems,Food, dairy, and beverage packaging lines,Tea, coffee, and related portioning systems, |
| ACG | Bermuda | Public Company | Insurance,Reinsurance,Mortgage, |
| THERMO FISHER SCIENTIFIC INC. | United States | Public Company | Life Sciences Solutions,Analytical Instruments,Specialty Diagnostics, |
| ELIZABETH COMPANIES | United States | Private Company | Prestige and heritage fragrances,Licensed designer and celebrity fragrances,Skincare (Elizabeth Arden, Ceramide, Prevage, Eight Hour, Pro), |
| FREUND | Japan | Private Company | Pharmaceutical granulation and coating equipment,Plant engineering and integrated systems,Pharmaceutical excipients, |
GEA GROUP AKTIENGESELLSCHAFT is a publicly traded company founded in 1881 with 19,670 employees operating in the United States.
KÖRBER AG is a German private company founded in 1946 with 10,665 employees.
IMA INDUSTRIA MACCHINE AUTOMATICHE SPA is an Italian private company founded in 1961 with 6,121 employees.
ACG is a publicly traded company based in Bermuda founded in 1995 with 8,000 employees.
THERMO FISHER SCIENTIFIC INC. is a publicly traded United States company founded in 1956 with 125,000 employees.
ELIZABETH COMPANIES is a United States-based private company founded in 1910 with 2,150 employees.
FREUND is a Japan-based private company founded in 1964 with 427 employees.
Brazil's pharmaceutical manufacturing equipment market is valued at USD 374.8 million in 2026 and is projected to reach USD 516.2 million by 2031.
Brazil's market is expected to grow at a compound annual growth rate (CAGR) of 5.5% between 2026 and 2031.
Key drivers include Brazil's strengthening regulatory framework, increased domestic pharmaceutical production capacity, government initiatives to boost local manufacturing, and rising adoption of automation and Industry 4.0 technologies.
Brazil's manufacturers are increasingly investing in tablet presses, filling machines, quality control systems, and digital solutions for operational efficiency and compliance.
Brazil's 5.5% CAGR is slightly below the global average of 6.2%, reflecting the country's mature but steadily expanding pharmaceutical manufacturing base within South America.
The research process for this study involved the systematic gathering, recording, and analysis of data on customers and companies operating in the pharmaceutical manufacturing equipment market. This process involved the extensive use of secondary sources, directories, and databases (Factiva and Oanda) to identify and collect valuable information for the comprehensive, technical, market-oriented, and commercial study of the pharmaceutical manufacturing equipment market. In-depth interviews were conducted with primary respondents, including experts from core and related industries, as well as preferred manufacturers, to obtain and verify critical qualitative and quantitative information and assess growth prospects. Key players in the pharmaceutical manufacturing equipment market were identified through secondary research, and their market rankings were determined through a combination of primary and secondary research. This research involved studying the annual reports of top players and conducting interviews with key industry experts, including CEOs, directors, and marketing executives.
Various sources were utilized in the secondary research process to identify and collect information relevant to this study. These include company annual reports, press releases, investor presentations, white papers, technology journals, certified publications, articles by recognized authors, directories, and databases. Secondary research was primarily used to gather key information about the industry’s value chain, the total pool of market players, market classification according to industry trends at the most detailed level, regional markets, and key developments from both market and technology-oriented perspectives.
Primary research was conducted to identify the segmentation types, key players, competitive landscape, and key market dynamics, including drivers, restraints, opportunities, challenges, and industry trends, as well as key strategies adopted by players operating in the pharmaceutical manufacturing equipment market. Extensive qualitative and quantitative analyses were performed on the complete market engineering process to list key information and insights throughout the report.
Extensive primary research has been conducted after gaining insights into the pharmaceutical manufacturing equipment market scenarios through secondary research. Several primary interviews were conducted with experts from the demand (region) and supply side (equipment type, end-product type, and technology) across four major geographic regions: North America, Europe, Asia Pacific, and RoW. Approximately 60% and 40% of the primary interviews were conducted from the supply and demand sides, respectively. These primary data have been collected through questionnaires, emails, and telephonic interviews.

Notes: The three tiers of companies have been defined based on their total/segmental revenue as of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million–USD 1 billion, and Tier 3 = <USD 500 million.
Other designations include sales, marketing, and product managers.
To know about the assumptions considered for the study, download the pdf brochure
In the complete market engineering process, top-down and bottom-up approaches and several data triangulation methods were implemented to estimate and validate the size of the pharmaceutical manufacturing equipment market and various other dependent submarkets. Key players were identified through secondary research, and their market share in the respective regions was determined through a combination of primary and secondary research. This entire research methodology involved studying the annual and financial reports of the top players, as well as conducting interviews with experts (CEOs, VPs, directors, and marketing executives) to gather key insights (both quantitative and qualitative).
All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the markets covered in this research study were accounted for, viewed in detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data. This data was consolidated and supplemented with detailed inputs and analysis from MarketsandMarkets and presented in this report.

After determining the overall market size through the estimation process, as explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain precise statistics for all segments and subsegments, market breakdown and data triangulation procedures were employed, as applicable. The data was triangulated by studying various factors and trends from the demand and supply sides. Additionally, the market has been validated using both top-down and bottom-up approaches.
The pharmaceutical manufacturing equipment market covers the global ecosystem involved in the development, production, processing, and packaging of pharmaceutical products across solid and liquid formulations. It includes machinery and integrated systems designed to ensure precision and sterility. These systems maintain regulatory compliance and operational efficiency. Equipment supports activities from raw material handling to final packaging. Manufacturers use these systems to maintain product quality. Large-scale and contract facilities rely on advanced machinery to optimize throughput.
With the given market data, MarketsandMarkets offers customizations according to the company’s specific needs. The following customization options are available for the report:
Full forecast, segment splits, and company analysis for all Pharmaceutical Manufacturing Equipment Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report